{"id":1816,"date":"2026-05-06T23:02:00","date_gmt":"2026-05-06T21:02:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=792e4fdfe6760e27a71249e490d9589f"},"modified":"2026-05-06T23:02:00","modified_gmt":"2026-05-06T21:02:00","slug":"glancy-prongay-wolke-rotter-llp-a-leading-securities-fraud-law-firm-encourages-regencell-bioscience-holdings-limited-rgc-shareholders-to-inquire-about-securities-fraud-class-action","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=1816","title":{"rendered":"Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Regencell Bioscience Holdings Limited (RGC) Shareholders To Inquire About Securities Fraud Class Action"},"content":{"rendered":"

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP<\/a>, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (\u201cRegencell\u201d or the \u201cCompany\u201d) (NASDAQ: RGC<\/a>) securities between October 28, 2024 and October 31, 2025<\/b>, inclusive (the \u201cClass Period\u201d). Regencell investors have until June 23, 2026 <\/b>to file a lead plaintiff motion.<\/p><\/a><\/a>

\nIF YOU SUFFERED A LOSS ON YOUR REGENCELL BIOSCIENCE HOLDINGS LIMITED (RGC) INVESTMENTS, CLICK <\/b>HERE<\/b><\/a> TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS<\/b><\/p>

\nWhat Happened?<\/b><\/p>

\nOn October 31, 2025, Regencell disclosed that \u201cfollowing recent volatility in the market for [its] Ordinary Shares, the Company received correspondence and a subpoena from the U.S. Department of Justice (\u2018DOJ\u2019), indicating that the DOJ is conducting an investigation into the trading in [its] Ordinary Shares.\u201d The Company further stated that \u201c[t]he DOJ has requested the production of documents and communications concerning these and other corporate operational, financial and accounting matters\u201d and that the Company \u201cexpect[s] to continue to incur significant legal costs and other expenses in connection with responding to the investigation\u201d and \u201cmay be required to pay fines, penalties, damages or settlement costs in excess of [its] insurance coverage, if any, related to the investigation.\u201d<\/p>

\nOn this news, Regencell\u2019s stock price fell $3.09, or 18.56%, to close at $13.56 per share on November 3, 2025, thereby injuring investors.<\/p>

\nWhat Is The Lawsuit About?<\/b><\/p>

\nThe complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, as well as failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Regencell was vulnerable and\/or subject to market manipulation; (2) the resulting volatility in the market for the Company\u2019s ordinary shares exposed Regencell\u2019s investors to significant financial risk; (3) all the foregoing subjected Regencell to a heightened risk of regulatory and\/or governmental scrutiny and enforcement action, as well as significant legal, monetary, and reputational harm; and (4) as a result, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis at all relevant times.<\/p>

\nIf you purchased or otherwise acquired Regencell securities during the Class Period, you may move the Court no later than June 23, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.<\/b><\/p>

\nContact Us To Participate or Learn More:<\/b><\/p>

\nIf you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:<\/p>

\nCharles Linehan, Esq.,\nGlancy Prongay Wolke & Rotter LLP,\n1925 Century Park East, Suite 2100,\nLos Angeles California 90067\nEmail: shareholders@glancylaw.com<\/a>Telephone: 310-201-9150,\nToll-Free: 888-773-9224\nVisit our website at www.glancylaw.com<\/a>.\nFollow us for updates on LinkedIn<\/a>, Twitter<\/a>, or Facebook<\/a>.<\/p>

\nIf you inquire by email, please include your mailing address, telephone number and number of shares purchased.<\/p>

\nTo be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class.<\/p>

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

\nGlancy Prongay Wolke & Rotter LLP,\n1925 Century Park East, Suite 2100\nLos Angeles, CA 90067\nCharles Linehan<\/b>Email: shareholders@glancylaw.com<\/a>Telephone: 310-201-9150\nToll-Free: 888-773-9224\nVisit our website at: www.glancylaw.com<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Regenc…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1816","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/1816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1816"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/1816\/revisions"}],"predecessor-version":[{"id":1817,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/1816\/revisions\/1817"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}